 | Up a level |
Ratz, Leonie, Brambillasca, Chiara, Bartke, Leandra, Huetzen, Maxim A., Goergens, Jonas, Leidecker, Orsolya, Jachimowicz, Ron D., van de Ven, Marieke, Proost, Natalie, Siteur, Bjorn, de Korte-Grimmerink, Renske, Bouwman, Peter 
ORCID: 0000-0002-9252-5896, Pulver, Emilia M., de Bruijn, Roebi, Isensee, Joerg, Hucho, Tim ORCID: 0000-0002-4147-9308, Pandey, Gaurav, van Lohuizen, Maarten, Mallmann, Peter, Reinhardt, Hans Christian, Jonkers, Jos ORCID: 0000-0002-9264-9792 and Puppe, Julian
(2022).
Combined inhibition of EZH2 and ATM is synthetic lethal in BRCA1-deficient breast cancer.
Breast Cancer Res., 24 (1).
LONDON:
BMC.
ISSN 1465-542X
Puppe, Julian, Opdam, Mark, Schouten, Philip C., Jozwiak, Katarzyna, Lips, Esther, Severson, Tesa, van de Ven, Marieke, Brambillasca, Chiara, Bouwman, Peter ORCID: 0000-0002-9252-5896, van Tellingen, Olaf ORCID: 0000-0002-1037-6269, Bernards, Rene, Wesseling, Jelle, Eichler, Christian, Thangarajah, Fabinshy, Malter, Wolfram, Pandey, Gaurav Kumar, Ozretic, Luka, Caldas, Carlos ORCID: 0000-0003-3547-1489, van Lohuizen, Maarten, Hauptmann, Michael ORCID: 0000-0001-8539-0148, Rhiem, Kerstin, Hahnen, Eric, Reinhardt, H. Christian, Buettner, Reinhard, Mallmann, Peter, Schoemig-Markiefka, Birgid, Schmutzler, Rita, Linn, Sabine and Jonkers, Jos ORCID: 0000-0002-9264-9792
(2019).
EZH2 Is Overexpressed in BRCA1-like Breast Tumors and Predictive for Sensitivity to High-Dose Platinum-Based Chemotherapy.
Clin. Cancer Res., 25 (14).
S. 4351 - 4363.
PHILADELPHIA:
AMER ASSOC CANCER RESEARCH.
ISSN 1557-3265